top of page

Health

Lundbeck Reports Seizure Reductions in Rare Childhood-Onset Epilepsies

AES 2025 data highlight continued seizure improvement in patients treated with bexicaserin through long-term follow-up.

Genetic Study Offers New Hope for Millions With ME and Long COVID

Largest genetic investigation of ME to date points to clear biological drivers and future clinical trial paths.

Scottish Brain Sciences Opens New Alzheimer’s Clinical Research Centre at ONE BioHub

Aberdeen expansion widens access to early-stage trials and strengthens Scotland’s position in global brain health innovation.

Placeholder image

Digital Cognitive Therapy Delivers Striking Cognitive Gains for UK Care Home Residents

A digital therapeutic designed to combat cognitive decline in people with dementia has produced remarkable improvements in cognitive and emotional outcomes in a recent UK pilot.

Body Clock Protein Found to Protect the Brain by Boosting Vital Energy Molecule

Circadian regulator REV-ERBα emerges as a brain-specific controller of NAD+ and tau pathology.

Qureight Model Shows Promise for Pulmonary Vascular Disease Management

Peer-reviewed study confirms the Vascul8™ model’s ability to improve patient care and reduce the need for invasive procedures following surgery for chronic thromboembolic pulmonary hypertension.

bottom of page